Innosuisse awarded Surgical Fusion Technologies a grant of 1.2 million Swiss francs
Schlieren, Zurich — Surgical Fusion Technologies has received a 1.2 million Swiss franc grant from Innosuisse to further develop its surgical method for sports medicine. The medtech company uses an ultrasound generator to create bioresorbable anchors that connect soft tissue to bone.
The Swiss innovation agency Innosuisse is supporting Surgical Fusion Technologies GmbH with the grant. According to a press release from the company, which is based at the Bio-Technopark Schlieren-Zurich, the grant will accelerate the development of next-generation soft tissue-bone fixation solutions. These solutions are intended to improve surgical outcomes in sports medicine and orthopedic procedures.
The project is called “Aligned Fibers for Ultrasonically Bioactivated Implants” (AFUBI). Project partners include the Institute for Materials Engineering and Plastics Processing at OST – University of Applied Sciences and Arts of Eastern Switzerland and the three institutes at the University of Applied Sciences and Arts of Northwestern Switzerland: Polymer Nanotechnology, Polymer Technology, and Chemistry & Bioanalytics.
The AFUBI project introduces a fixation concept that uses ultrasound to activate fully bioresorbable anchors, which fuse directly with cancellous bone during implantation. The SupraFusion platform is designed to accelerate bone integration by controlling the release of bioactive bioglass fibers. This technology allows for micro-invasive anchoring, which causes less bone trauma than current anchors because it liquefies the implant surface locally using ultrasound.
“This extremely welcome grant from Innosuisse is an important validation of our technology and its potential to redefine how bioresorbable implants bond with bone,” said Chief Technology Officer Jörg Mayer. “The AFUBI project allows us to develop a more advanced minimally invasive fixation approach that combines mechanical performance with biologically active interfaces.”
(translated from https://punkt4.info/)